A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
Clinical trial NCT07154342 · RECRUITING
Trial details
- NCT number
- NCT07154342
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-15
- Primary completion
- 2026-04-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.